Hims & Hers Health (HIMS)-Update
Hims & Hers has ended its extended corrective phase. We expect this stock to follow its long-term uptrend and to
1 min read
Health & Biotech
From pharmaceutical giants and health insurers to cutting-edge biotech and gene-editing pioneers — this sector tracks the companies advancing human health and medicine.
22 posts
Moderna (MRNA)-Update
Moderna has officially been an enormous success.
We defined our Fibonacci retracement zone on July 13th, which was activated on
1 min read
UnitedHealth Group (UNH)-Update
United Health Group has successfully found a bottom following a significant and sharp sell-off. This sell-off formed the first leg
1 min read
Moderna (MRNA)-Update
Moderna has reached our defined Fibonacci retracement zone, which we outlined in our previous update on July 13th (https://monalytics.
1 min read
Moderna (MRNA)-Update
Moderna has surpassed our expectations and is displaying stronger bullish impulse than previously anticipated. If this plays out as expected,
1 min read
Merck (MRK)-Update
Merck has successfully validated our expectation of building its local bottom and followed our exoectation into our previusly defined Fibonacci
1 min read